This inventor holds 2 USPTO granted patents. Top assignee: Korea Centers for Disease Control and Prevention. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations by Sang Gu Yeo
Introduction
Sang Gu Yeo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of vaccine development, particularly through his innovative work with vaccinia virus strains. With a total of 2 patents, his research focuses on creating safer and more effective vaccine delivery systems.
Latest Patents
One of his latest patents is the "Attenuated vaccinia virus KVAC103 strain." This strain was developed by subculturing a vaccinia virus 103 times in VERO cells. The KVAC103 strain exhibits significantly low toxicity and reduced skin lesions while effectively inducing immune responses to poxvirus. This makes it a promising candidate for use as a poxvirus vaccine with fewer side effects.
Another notable patent is the "Recombinant vaccinia virus derived from KVAC103 strain." This invention involves a novel recombinant virus vector created by inserting an exogenous gene into the KVAC103 strain. The recombinant virus vector serves as a safe vaccine delivery vehicle in mammals. It has enhanced proliferation capabilities in cultured cells and expresses a higher level of exogenous antigens, leading to improved immunogenic efficacy. These recombinant virus vectors have potential applications in vaccines for disease prevention, therapeutic vaccines, and molecular biological studies.
Career Highlights
Sang Gu Yeo is affiliated with the Korea Centers for Disease Control and Prevention, where he continues to advance his research in vaccine technology. His work is crucial in addressing public health challenges through innovative vaccine solutions.
Collaborations
He collaborates with notable colleagues, including Ho Sun Son and Sang Won Lee, contributing to a dynamic research environment focused on vaccine development.
Conclusion
Sang Gu Yeo's innovative work in the field of vaccine development highlights the importance of research in creating safer and more effective medical solutions. His contributions are paving the way for advancements in immunization and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile